Status:
COMPLETED
ScreenNC, a Study to Determine the Number of Asymptomatic Individuals Who Have Antibodies to the Virus That Causes COVID-19
Lead Sponsor:
University of North Carolina, Chapel Hill
Conditions:
Asymptomatic Condition
Infection Viral
Eligibility:
All Genders
18-99 years
Brief Summary
Purpose: To determine the number of asymptomatic individuals who have antibodies to SARS-CoV-2, the virus which causes COVID-19
Detailed Description
ScreenNC is design ed for comprehensive virus screening and serology to assess exposure to SAR-CoV2 in persons not-indicated for COVID-19 testing as per the CDC screening algorithm and implemented at ...
Eligibility Criteria
Inclusion
- Individuals aged 18-99 who arrive at any participating UNC Healthcare clinic for care and who have a medical record in UNC EPIC.
- Patients may be included if they have completed the quarantine as recommended by the CDC and at least 4 weeks since the initial positive COVID-19 NP test.
Exclusion
- Any individual arriving at any participating UNC Healthcare clinic for diagnosis or treatment of respiratory symptoms meeting the following COVID-19 clinical evaluation criteria:
- Developed non-allergy respiratory symptoms of cough or shortness of breath in the past 7 days
- AND
- Meet ONE OR MORE of these criteria
- Had close contact (within 6 feet for 10 or more minutes) with a person diagnosed with COVID-19
- Works in a healthcare setting
- Is pregnant or postpartum within 2 weeks of delivery
- Is morbidly obese: BMI = 40 or 100 pounds over ideal body weight
- Diabetes mellitus
- Immunosuppression, including caused by medications or by HIV infection
- Pulmonary disease, including asthma
- Cardiovascular disease
- Hypertensive disease
- Renal disease
- Hepatic disease
- Hematologic disease, including sickle cell disease
- Neurological condition that limits movement
- Moderate to severe developmental delay
Key Trial Info
Start Date :
April 28 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 28 2022
Estimated Enrollment :
6313 Patients enrolled
Trial Details
Trial ID
NCT04367740
Start Date
April 28 2020
End Date
February 28 2022
Last Update
January 9 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Center for Environmental Medicine, Asthma and Lung Biology
Chapel Hill, North Carolina, United States, 27599